Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06580730
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-24
Brief Title:
Endovascular Treatment for Stroke Post 1 Day 24 Hours
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Endovascular Treatment Post 1 Day 24 Hours a Randomized Controlled Clinical Trial on Efficacy and Safety for Stroke
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ETP-1
Brief Summary:
Acute ischemic stroke AIS is one of the leading causes of disability and mortality worldwide The treatment of this condition is time-critical with the key to effective therapy being the early recanalization of the occluded vessel and restoration of blood flow to salvage the ischemic penumbra tissue Currently the time window for endovascular treatment in the anterior circulation can be extended up to 24 hours Exploring endovascular treatments for patients beyond this time window from 24 hours to 30 days could mean hope for a greater number of AIS patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None